These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 16361537

  • 1. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, Wu WZ, Liu YK, Ye SL, Tang ZY.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 15; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 4. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q.
    Br J Cancer; 1999 Nov 01; 81(5):814-21. PubMed ID: 10555751
    [Abstract] [Full Text] [Related]

  • 5. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.
    Zhang T, Sun HC, Zhou HY, Luo JT, Zhang BL, Wang P, Wang L, Qin LX, Ren N, Ye SL, Li Q, Tang ZY.
    Cancer Lett; 2010 Apr 28; 290(2):204-10. PubMed ID: 19822391
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct 28; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 7. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.
    Clin Cancer Res; 2010 Feb 01; 16(3):967-77. PubMed ID: 20103676
    [Abstract] [Full Text] [Related]

  • 8. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, Yeh MM, Alpers CE, Fausto N.
    Differentiation; 2007 Nov 01; 75(9):843-52. PubMed ID: 17999742
    [Abstract] [Full Text] [Related]

  • 9. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
    Torimura T, Ueno T, Kin M, Taniguchi E, Nakamura T, Inoue K, Sakata R, Hashimoto O, Sakamoto M, Ohira H, Kumashiro R, Sata M, Yano H, Kojiro M, Veitonmaki N, Cao Y.
    Gastroenterology; 2006 Apr 01; 130(4):1301-10. PubMed ID: 16618420
    [Abstract] [Full Text] [Related]

  • 10. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST.
    Clin Cancer Res; 2006 Dec 01; 12(23):6910-9. PubMed ID: 17145808
    [Abstract] [Full Text] [Related]

  • 11. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D.
    Clin Cancer Res; 2003 Sep 15; 9(11):4221-6. PubMed ID: 14519649
    [Abstract] [Full Text] [Related]

  • 12. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H, Ngo VC, Fargnoli J, Ayers M, Soo KC, Koong HN, Thng CH, Ong HS, Chung A, Chow P, Pollock P, Byron S, Tran E.
    Clin Cancer Res; 2008 Oct 01; 14(19):6146-53. PubMed ID: 18829493
    [Abstract] [Full Text] [Related]

  • 13. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma.
    Lam CT, Yang ZF, Lau CK, Tam KH, Fan ST, Poon RT.
    Clin Cancer Res; 2011 May 15; 17(10):3123-33. PubMed ID: 21421859
    [Abstract] [Full Text] [Related]

  • 14. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
    Zhang D, Li B, Shi J, Zhao L, Zhang X, Wang C, Hou S, Qian W, Kou G, Wang H, Guo Y.
    Cancer Res; 2010 Mar 15; 70(6):2495-503. PubMed ID: 20197464
    [Abstract] [Full Text] [Related]

  • 15. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST.
    Clin Cancer Res; 2004 Nov 15; 10(22):7629-36. PubMed ID: 15569995
    [Abstract] [Full Text] [Related]

  • 16. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 17. [Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials].
    Li Y, Tang Z, Ye S, Liu B, Liu Y, Chen J, Xue Q.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov 15; 24(6):533-6. PubMed ID: 12667318
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1666-70. PubMed ID: 16854316
    [Abstract] [Full Text] [Related]

  • 19. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 20. [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
    Huang XY, Huang ZL, Tang ZY, Xu B, Zheng Q, Zhou J, Wang L, Ye SL.
    Zhonghua Yi Xue Za Zhi; 2010 May 11; 90(18):1278-82. PubMed ID: 20646604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.